Pineda Mario Javier, Orton Brannon R, Overbaugh Julie
Division of Human Biology, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N., Seattle, WA 98109, USA.
Virology. 2007 Jul 5;363(2):310-8. doi: 10.1016/j.virol.2007.02.002. Epub 2007 Mar 9.
The replication of human immunodeficiency type-1 (HIV-1) is restricted in macaque cells, in part due to host factors that provide intrinsic immunity after entry. Here we show that a rhesus macaque epithelial cell line engineered to express human CD4, sMAGI cells, has at least two post-entry restrictions to HIV-1 replication: one that is dependent on a previously described post-entry restriction factor of macaque cells, TRIM5alpha, and another that is primarily TRIM5alpha-independent. The TRIM5alpha restriction, which was observed with particles that had an HIV-1 core pseudotyped with VSV-G envelope, is saturable and can be completely abrogated by introducing TRIM5alpha-specific siRNA into the cells. A similar TRIM5alpha-dependent restriction was observed when sMAGI cells expressing human CCR5 were infected with an R5-HIV-1. In contrast, even when viruses enter sMAGI cells using CD4 and an endogenous rhesus coreceptor at levels sufficient to saturate TRIM5alpha, they do not productively infect the sMAGI cells. Nor does treatment of sMAGI cells with TRIM5alpha-specific siRNA relieve this post-entry restriction; this was true whether the HIV-1 core was pseudotyped with SIV envelope or an R5-HIV-1 envelope. Together these data suggest that there is an alternate restriction to replication, here called Lv3, that is encountered by viruses that enter via interaction with CD4 and an endogenous rhesus coreceptor. Thus, these findings suggest that post-entry events are dependent upon the mechanism by which HIV-1 enters the cell.
1型人类免疫缺陷病毒(HIV-1)在猕猴细胞中的复制受到限制,部分原因是宿主因子在病毒进入后提供了固有免疫。在此,我们表明,经基因工程改造以表达人类CD4的恒河猴上皮细胞系,即sMAGI细胞,对HIV-1复制至少有两种进入后限制:一种依赖于先前描述的猕猴细胞进入后限制因子TRIM5α,另一种主要不依赖于TRIM5α。在用VSV-G包膜假型化的HIV-1核心颗粒中观察到的TRIM5α限制是可饱和的,并且通过将TRIM5α特异性siRNA引入细胞可完全消除。当表达人类CCR5的sMAGI细胞感染R5-HIV-1时,观察到类似的TRIM5α依赖性限制。相反,即使病毒使用CD4和内源性恒河猴共受体以足以饱和TRIM5α的水平进入sMAGI细胞,它们也不能有效感染sMAGI细胞。用TRIM5α特异性siRNA处理sMAGI细胞也不能解除这种进入后限制;无论HIV-1核心是用SIV包膜还是R5-HIV-1包膜假型化,都是如此。这些数据共同表明,对于通过与CD4和内源性恒河猴共受体相互作用进入的病毒,存在一种称为Lv3的复制替代限制。因此,这些发现表明进入后事件取决于HIV-1进入细胞的机制。